Hantavirus GnT elements mediate TRAF3 binding and inhibit RIG-I/TBK1-directed beta interferon transcription by blocking IRF3 phosphorylation

Journal of Virology

Volumn 88, Issue 4, 2014, Pages 2246-2259

  Matthys, Valery S ^a   Cimica, Velasco ^a   Dalrymple, Nadine A ^a   Glennon, Nicole B ^a   Bianco, Chris ^a   Mackow, Erich R ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION REGULATION, VIRAL; HANTAVIRUS; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; INTERFERON REGULATORY FACTOR-3; INTERFERON-BETA; MUTAGENESIS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 3; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 84893458405     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02647-13     Document Type: Article

References (74)

1. Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, Ksiazek TG, Rollin PE, Nichol S, Umland ET, Moolenaar RL, Reef SE, Nolte KB, Gallaher MM, Butler JC, Breiman RF, Hantavirus Study Group. 1994. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N. Engl. J. Med. 330:949-955.
2. Hjelle B, Jenison S, Torrez-Martinez N, Yamada T, Nolte K, Zumwalt R, MacInnes K, Myers G. 1994. A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses. J. Virol. 68:592-596.
3. Lee HW. 1982. Hemorrhagic fever with renal syndrome (HFRS). Scand. J. Infect. Dis. Suppl. 36:82-85.
4. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, Sanchez A, Childs J, Zaki S, Peters CJ. 1993. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262:914-917. http://dx.doi.org/10.1126/science.8235615.
5. Schmaljohn C. 2001. Bunyaviridae and their replication, p 1581-1602. In Knipe PM, Howley PM, Cohen JL, Griffin DL, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, vol 1. Lipppincott-Raven, Philadelphia, PA.
6. Yanagihara R, Silverman DJ. 1990. Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch. Virol. 111:281-286. http://dx.doi.org/10.1007/BF01311063.
7. Zaki S, Greer P, Coffield L, Goldsmith C, Nolte K, Foucar K, Feddersen R, Zumwalt R, Miller G, Rollin P, Ksiazek T, Nichol S, Peters C. 1995. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am. J. Pathol. 146:552-579.
8. Lahdevirta J. 1982. Clinical features of HFRS in Scandinavia as compared with East Asia. Scand. J. Infect. Dis. Suppl. 36:93-95.
9. Lahdevirta J, Enger E, Hunderi OH, Traavik T, Lee HW. 1982. Hantaan virus is related to hemorrhagic fever with renal syndrome in Norway. Lancet ii:606.
10. Lee HW, Baek LJ, Johnson KM. 1982. Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J. Infect. Dis. 146:638-644. http://dx.doi.org/10.1093/infdis/146.5.638.
11. Schmaljohn C, Hjelle B. 1997. Hantaviruses: a global disease problem. Emerg. Infect. Dis. 3:95-104. http://dx.doi.org/10.3201/eid0302.970202.
12. Chang B, Crowley M, Campen M, Koster F. 2007. Hantavirus cardiopulmonary syndrome. Semin. Respir. Crit. Care Med. 28:193-200. http://dx.doi.org/10.1055/s-2007-976491.
13. Enria D, Padula P, Segura EL, Pini N, Edelstein A, Posse CR, Weissenbacher MC. 1996. Hantavirus pulmonary syndrome in Argentina. Possibility of person to person transmission. Medicina 56:709-711.
14. Lopez N, Padula P, Rossi C, Lazaro ME, Franze-Fernandez MT. 1996. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 220:223-226. http://dx.doi.org/10.1006/viro.1996.0305.
15. Plyusnin A, Vapalahti O, Lankinen H, Lehvaslaiho H, Apekina N, Myasnikov Y, Kallio-Kokko H, Henttonen H, Lundkvist A, Brummer-Korvenkontio M. 1994. Tula virus: a newly detected hantavirus carried by European common voles. J. Virol. 68:7833-7839.
16. Yanagihara R, Daum CA, Lee PW, Baek LJ, Amyx HL, Gajdusek DC, Gibbs CJ. 1987. Serological survey of Prospect Hill virus infection in indigenous wild rodents in the USA. Trans. R. Soc. Trop. Med. Hyg. 81: 42-45. http://dx.doi.org/10.1016/0035-9203(87)90275-6.
17. Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER. 1999. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J. Virol. 73:3951-3959.
18. Gavrilovskaya IN, Shepley M, Shaw R, Ginsberg MH, Mackow ER. 1998. beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. U.S.A. 95:7074-7079. http://dx.doi.org/10.1073/pnas.95.12.7074.
19. Alff PJ, Gavrilovskaya IN, Gorbunova E, Endriss K, Chong Y, Geimonen E, Sen N, Reich NC, Mackow ER. 2006. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I-and TBK-1-directed interferon responses. J. Virol. 80:9676-9686. http://dx.doi.org/10.1128/JVI.00508-06.
20. Alff PJ, Sen N, Gorbunova E, Gavrilovskaya IN, Mackow ER. 2008. The NY-1 hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation. J. Virol. 82:9115-9122. http://dx.doi.org/10.1128/JVI.00290-08.
21. Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya IN, Mackow ER. 2002. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc. Natl. Acad. Sci. U.S.A. 99:13837-13842. http://dx.doi.org/10.1073/pnas.192298899.
22. Pensiero MN, Hay J. 1992. The Hantaan virus M-segment glycoproteins G1 and G2 can be expressed independently. J. Virol. 66:1907-1914.
23. Hepojoki J, Strandin T, Wang H, Vapalahti O, Vaheri A, Lankinen H. 2010. Cytoplasmic tails of hantavirus glycoproteins interact with the nucleocapsid protein. J. Gen. Virol. 91:2341-2350. http://dx.doi.org/10.1099/vir.0.021006-0.
24. Matthys V, Gorbunova EE, Gavrilovskaya IN, Pepini T, Mackow ER. 2011. The C-terminal 42 residues of the TULV Gn protein regulate interferon induction. J. Virol. 85:4752-4760. http://dx.doi.org/10.1128/JVI.01945-10.
25. Matthys V, Mackow ER. 2012. Hantavirus regulation of type I interferon responses. Adv. Virol. 2012:524024. http://dx.doi.org/10.1155/2012/524024.
26. Sen N, Sen A, Mackow ER. 2007. Degrons at the C terminus of the pathogenic but not the nonpathogenic hantavirus G1 tail direct proteasomal degradation. J. Virol. 81:4323-4330. http://dx.doi.org/10.1128/JVI.02279-06.
27. Hiscott J. 2007. Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 282:15325-15329. http://dx.doi.org/10.1074/jbc.R700002200.
28. Seth RB, Sun L, Chen ZJ. 2006. Antiviral innate immunity pathways. Cell Res. 16:141-147. http://dx.doi.org/10.1038/sj.cr.7310019.
29. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988. http://dx.doi.org/10.1038/ni1243.
30. Lin R, Lacoste J, Nakhaei P, Sun Q, Yang L, Paz S, Wilkinson P, Julkunen I, Vitour D, Meurs E, Hiscott J. 2006. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J. Virol. 80:6072-6083. http://dx.doi.org/10.1128/JVI.02495-05.
31. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C. 2006. RIG-I-mediated antiviral responses to singlestranded RNA bearing 5'-phosphates. Science 314:997-1001. http://dx.doi.org/10.1126/science.1132998.
32. Yoneyama M, Fujita T. 2007. RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. Cytokine Growth Factor Rev. 18: 545-551. http://dx.doi.org/10.1016/j.cytogfr.2007.06.023.
33. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737. http://dx.doi.org/10.1038/ni1087.
34. Charoenthongtrakul S, Gao L, Parvatiyar K, Lee D, Harhaj EW. 2013. RING finger protein 11 targets TBK1/IKKi kinases to inhibit antiviral signaling. PLoS One 8:e53717. http://dx.doi.org/10.1371/journal.pone.0053717.
35. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496. http://dx.doi.org/10.1038/ni921.
36. Hacker H, Tseng PH, Karin M. 2011. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat. Rev. Immunol. 11:457-468. http://dx.doi.org/10.1038/nri2998.
37. Matsui K, Kumagai Y, Kato H, Sato S, Kawagoe T, Uematsu S, Takeuchi O, Akira S. 2006. Cutting edge: role of TANK-binding kinase 1 and inducible IkappaB kinase in IFN responses against viruses in innate immune cells. J. Immunol. 177:5785-5789. http://www.jimmunol.org/content/177/9/5785.
38. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, Perry A, Cheng G. 2006. Critical role of TRAF3 in the Toll-like receptordependent and-independent antiviral response. Nature 439:208-211. http://dx.doi.org/10.1038/nature04374.
39. Shen RR, Hahn WC. 2011. Emerging roles for the non-canonical IKKs in cancer. Oncogene 30:631-641. http://dx.doi.org/10.1038/onc.2010.493.
40. Tu D, Zhu Z, Zhou AY, Yun CH, Lee KE, Toms AV, Li Y, Dunn GP, Chan E, Thai T, Yang S, Ficarro SB, Marto JA, Jeon H, Hahn WC, Barbie DA, Eck MJ. 2013. Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep. 3:747-758. http://dx.doi.org/10.1016/j.celrep.2013.01.033.
41. Lazear HM, Lancaster A, Wilkins C, Suthar MS, Huang A, Vick SC, Clepper L, Thackray L, Brassil MM, Virgin HW, Nikolich-Zugich J, Moses AV, Gale M, Jr, Fruh K, Diamond MS. 2013. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 9:e1003118. http://dx.doi.org/10.1371/journal.ppat.1003118.
42. Panne D. 2008. The enhanceosome. Curr. Opin. Struct. Biol. 18:236-242. http://dx.doi.org/10.1016/j.sbi.2007.12.002.
43. Der SD, Zhou A, Williams BR, Silverman RH. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 95:15623-15628. http://dx.doi.org/10.1073/pnas.95.26.15623.
44. Hu H, Brittain GC, Chang JH, Puebla-Osorio N, Jin J, Zal A, Xiao Y, Cheng X, Chang M, Fu YX, Zal T, Zhu C, Sun SC. 2013. OTUD7B controls non-canonical NF-kappaB activation through deubiquitination of TRAF3. Nature 494:371-374. http://dx.doi.org/10.1038/nature11831.
45. Belgnaoui SM, Paz S, Samuel S, Goulet ML, Sun Q, Kikkert M, Iwai K, Dikic I, Hiscott J, Lin R. 2012. Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex. Cell Host Microbe 12:211-222. http://dx.doi.org/10.1016/j.chom.2012.06.009.
46. Mao AP, Li S, Zhong B, Li Y, Yan J, Li Q, Teng C, Shu HB. 2010. Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response. J. Biol. Chem. 285:9470-9476. http://dx.doi.org/10.1074/jbc.M109.071043.
47. Spiropoulou CF, Albarino CG, Ksiazek TG, Rollin PE. 2007. Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J. Virol. 81:2769-2776. http://dx.doi.org/10.1128/JVI.02402-06.
48. Geimonen E, Fernandez I, Gavrilovskaya IN, Mackow ER. 2003. Tyrosine residues direct the ubiquitination and degradation of the NY-1 hantavirus G1 cytoplasmic tail. J. Virol. 77:10760-10868. http://dx.doi.org/10.1128/JVI.77.20.10760-10768.2003.
49. Geimonen E, LaMonica R, Springer K, Farooqui Y, Gavrilovskaya IN, Mackow ER. 2003. Hantavirus pulmonary syndrome-associated hantaviruses contain conserved and functional ITAM signaling elements. J. Virol. 77:1638-1643. http://dx.doi.org/10.1128/JVI.77.2.1638-1643.2003.
50. Rothenfusser S, Goutagny N, DiPerna G, Gong M, Monks BG, Schoenemeyer A, Yamamoto M, Akira S, Fitzgerald KA. 2005. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 175:5260-5268. http://www.jimmunol.org/content/175/8/5260.
51. Sumpter R, Jr, Loo YM, Foy E, Li K, Yoneyama M, Fujita T, Lemon SM, Gale M, Jr. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689-2699. http://dx.doi.org/10.1128/JVI.79.5.2689-2699.2005.
52. Lin R, Heylbroeck C, Pitha PM, Hiscott J. 1998. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol. Cell. Biol. 18:2986-2996.
53. Tom R, Bisson L, Durocher Y. 2008. Transfection of HEK293-EBNA1 cells in suspension with linear PEI for production of recombinant proteins. CSH Protoc. 2008:pdb.prot4977. http://dx.doi.org/10.1101/pdb.prot4977.
54. Lei CQ, Zhang Y, Xia T, Jiang LQ, Zhong B, Shu HB. 2013. FoxO1 negatively regulates cellular antiviral response by promoting degradation of IRF3. J. Biol. Chem. 288:12596-12604. http://dx.doi.org/10.1074/jbc.M112.444794.
55. Yang B, Wang J, Sun B. 2013. Trim21: a novel negative regulator in DNA sensor signaling. Cell. Mol. Immunol. 10:190-192. http://dx.doi.org/10.1038/cmi.2013.12.
56. Zhang Z, Bao M, Lu N, Weng L, Yuan B, Liu YJ. 2013. The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA. Nat. Immunol. 14:172-178. http://dx.doi.org/10.1038/ni.2492.
57. Higgs R, Ni Gabhann J, Ben Larbi N, Breen EP, Fitzgerald KA, Jefferies CA. 2008. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J. Immunol. 181:1780-1786.
58. Yu Y, Hayward GS. 2010. The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3. Immunity 33:863-877. http://dx.doi.org/10.1016/j.immuni.2010.11.027.
59. Zhang M, Wang L, Zhao X, Zhao K, Meng H, Zhao W, Gao C. 2012. TRAF-interacting protein (TRIP) negatively regulates IFN-beta production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1. J. Exp. Med. 209:1703-1711. http://dx.doi.org/10.1084/jem.20120024.
60. Hacker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, Wang GG, Kamps MP, Raz E, Wagner H, Hacker G, Mann M, Karin M. 2006. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:204-207. http://dx.doi.org/10.1038/nature04369.
61. Huang Y, Liu H, Ge R, Zhou Y, Lou X, Wang C. 2012. UXT-V1 facilitates the formation of MAVS antiviral signalosome on mitochondria. J. Immunol. 188:358-366.
62. Stacey KB, Breen E, Jefferies CA. 2012. Tyrosine phosphorylation of the E3 ubiquitin ligase TRIM21 positively regulates interaction with IRF3 and hence TRIM21 activity. PLoS One 7:e34041. http://dx.doi.org/10.1371/journal.pone.0034041.
63. Oudshoorn D, Versteeg GA, Kikkert M. 2012. Regulation of the innate immune system by ubiquitin and ubiquitin-like modifiers. Cytokine Growth Factor Rev. 23:273-282. http://dx.doi.org/10.1016/j.cytogfr.2012.08.003.
64. Honda K, Taniguchi T. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6:644-658. http://dx.doi.org/10.1038/nri1900.
65. Paz S, Vilasco M, Arguello M, Sun Q, Lacoste J, Nguyen TL, Zhao T, Shestakova EA, Zaari S, Bibeau-Poirier A, Servant MJ, Lin R, Meurs EF, Hiscott J. 2009. Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter. Mol. Cell. Biol. 29:3401-3412. http://dx.doi.org/10.1128/MCB.00880-08.
66. Zhou AY, Shen RR, Kim E, Lock YJ, Xu M, Chen ZJ, Hahn WC. 2013. IKKepsilon-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex. Cell Rep. 3:724-733. http://dx.doi.org/10.1016/j.celrep.2013.01.031.
67. Jaaskelainen KM, Kaukinen P, Minskaya ES, Plyusnina A, Vapalahti O, Elliott RM, Weber F, Vaheri A, Plyusnin A. 2007. Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter. J. Med. Virol. 79:1527-1536. http://dx.doi.org/10.1002/jmv.20948.
68. Levine JR, Prescott J, Brown KS, Best SM, Ebihara H, Feldmann H. 2010. Antagonism of type I interferon responses by New World hantaviruses. J. Virol. 84:11790-11801. http://dx.doi.org/10.1128/JVI.00916-10.
69. Khaiboullina SF, Rizvanov AA, Deyde VM, St Jeor SC. 2005. Andes virus stimulates interferon-inducible MxA protein expression in endothelial cells. J. Med. Virol. 75:267-275. http://dx.doi.org/10.1002/jmv.20266.
70. Odorizzi PM, Wherry EJ. 2013. Immunology. An interferon paradox. Science 340:155-156. http://dx.doi.org/10.1126/science.1237568.
71. Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, Welch M, Schreiber RD, de la Torre JC, Oldstone MB. 2013. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340:207-211. http://dx.doi.org/10.1126/science.1235214.
72. Gomez D, Reich NC. 2003. Stimulation of primary human endothelial cell proliferation by IFN. J. Immunol. 170:5373-5381. http://www.jimmunol.org/content/170/11/5373.full.pdf.
73. Korherr C, Gille H, Schafer R, Koenig-Hoffmann K, Dixelius J, Egland KA, Pastan I, Brinkmann U. 2006. Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway. Proc. Natl. Acad. Sci. U.S.A. 103:4240-4245. http://dx.doi.org/10.1073/pnas.0511319103.
74. Ng MH, Ho TH, Kok KH, Siu KL, Li J, Jin DY. 2011. MIP-T3 is a negative regulator of innate type I IFN response. J. Immunol. 187:6473-6482. http://dx.doi.org/10.4049/jimmunol.1100719.